Legal and financial professionals depend on Pharm3r’s diverse and authoritative data sources for relevant and accurate insight into the life sciences sector. From monitoring litigation trends and evaluating company and product risks to conducting thorough M&A due diligence, Pharm3r’s platform is an indispensable tool for making informed decisions confidently.
Whether exploring potential partnerships and strategic business expansions or evaluating and measuring litigation risks across entire portfolios, Pharm3r provides critical fact-based support.
Evaluate and compare company risk profiles, product performance, patents, regulatory compliance, clinical trial outcomes, and supply chain vulnerabilities over time to enable thorough risk assessments.
Track litigation trends, review existing risk vectors and predict and assess aggregated liability across product portfolios that link adverse events to litigation probability.
Minimize time spent researching the history of legal entities and products with custom tools and reports making it faster and easier to collect information.
A comprehensive perspective on manufacturers, products, and their performance
Insightful analysis of emerging product development trends
The ability to compare product offerings and operational risks
Prospect lists and business development opportunities